These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26964879)

  • 1. Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes.
    Chen J; Zhang B; Xia F; Xie Y; Jiang S; Su R; Lu Y; Wu W
    Nanoscale; 2016 Apr; 8(13):7127-36. PubMed ID: 26964879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the structure and stability of cyclic peptide based nanotubes using oligomeric approach: a computational chemistry investigation.
    Vijayaraj R; Sundar Raman S; Mahesh Kumar R; Subramanian V
    J Phys Chem B; 2010 Dec; 114(49):16574-83. PubMed ID: 21087024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical studies on the transport mechanism of 5-fluorouracil through cyclic peptide based nanotubes.
    Vijayaraj R; Van Damme S; Bultinck P; Subramanian V
    Phys Chem Chem Phys; 2013 Jan; 15(4):1260-70. PubMed ID: 23229174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug conjugation to cyclic peptide-polymer self-assembling nanotubes.
    Blunden BM; Chapman R; Danial M; Lu H; Jolliffe KA; Perrier S; Stenzel MH
    Chemistry; 2014 Sep; 20(40):12745-9. PubMed ID: 25146103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
    Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
    Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of a Biocompatible 1D Coordination Polymer as Anti-Breast Cancer Drug Carrier, 5-Fu: In Vitro and in Vivo Studies.
    Rezaei M; Abbasi A; Dinarvand R; Jeddi-Tehrani M; Janczak J
    ACS Appl Mater Interfaces; 2018 May; 10(21):17594-17604. PubMed ID: 29771107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
    Jin Y; Yang F; Du L
    Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion channel models based on self-assembling cyclic peptide nanotubes.
    Montenegro J; Ghadiri MR; Granja JR
    Acc Chem Res; 2013 Dec; 46(12):2955-65. PubMed ID: 23898935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide.
    Chen Y; Zhang W; Huang Y; Gao F; Fang X
    PLoS One; 2016; 11(3):e0149952. PubMed ID: 26930626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights on the cyclic peptide nanotube-mediated transportation of antitumor drug 5-fluorouracil.
    Liu H; Chen J; Shen Q; Fu W; Wu W
    Mol Pharm; 2010 Dec; 7(6):1985-94. PubMed ID: 20964368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
    Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
    Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.
    Liu Y; Steiniger SC; Kim Y; Kaufmann GF; Felding-Habermann B; Janda KD
    Mol Pharm; 2007; 4(3):435-47. PubMed ID: 17373820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.